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ABSTRACT  
The present investigation was aimed to isolate banana starch (BS), synthesis of banana starch tartrate (BST), characterization, and application 
as a novel disintegrant in telmisartan tablets. Starch tartrate was synthesized by the esterification process by the treatment of tartaric acid on 
the backbone of the BS. Synthesized BST was found to be fine, slightly free-flowing and crystalline powder. The synthesized BST was subjected 
to Scanning Electron Microscopy (SEM) and micrometric evaluation. Flow properties of BS and BST were determined as an angle of repose, bulk 
density, tapped density, Carr’s index, Hausner’s ratio, etc. BST exhibited good swelling properties and showed no gelling at 100°C but it was 
transformed into a clear solution. Fourier transform infrared spectra (FTIR) did not show the presence of any significant interaction between 
BST and Telmisartan(T). The direct compression technique was employed in formulating telmisartan tablets using BST sodium starch glycolate 
and crospovidone as a disintegrant.  Tablets were comparatively evaluated for weight variation, thickness, hardness, friability, and 
disintegration. The tablets formulated using BS and BST passed prescribed evaluation tests for weight variation, friability, hardness, and 
thickness. The tablets formulated using BST as disintegrant gave optimum disintegration compared to those tablets containing sodium starch 
glycolate and crospovidone sodium super disintegrants. Evaluations indicated that synthesized BST shows qualitatively and quantitatively good 
disintegration characteristics in comparison to super disintegrants in telmisartan tablet formulation. These results suggest that the synthes ized 
BST could be used as a novel semi-synthetic disintegrant in dispersible tablet formulations. 
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1. INTRODUCTION 
Starch is polymeric substance derived from carbohydrate 
and composed of long-chain polysaccharides containing 
amylose and amylopectin units with branched-chain1.  
Starches are used as excipients in pharmaceuticals 
principally derived from corn, wheat, and potato which are 
monographed in some pharmacopeia.  Starch is one of the 
most commonly used binders, lubricant, and disintegrant in 
the formulations of solid dosage forms. The swelling ability 
of the starch is accountable for its disintegration properties. 
Disintegrating agents exist as the hydrophilic ingredients 
when interacting with saliva or gastric fluid absorbs water, 
swells that cause disintegration of tablets2. Even though Corn 
starch is broadly used in pharmaceutical formulations, 
starches from supplementary botanical sources have 
revealed diverse functional properties such as swelling, 
gelling, and water binding capability. As influential 
disintegrant starches are valuable in the formulation of 
insoluble drug substances3.  The unripe fruit of banana is 
considered as a source of eco-friendly materials. The pulp of 
unripe banana fruit is made up of 60-80% starch based on 
dry weight with a percentage that is equal to any other 
source of starch4,5. Modified starches have a comprehensive 
range of properties from the binder to disintegrant and 
preventing moisture entrapment in tablet formulations. The 
modified starches shown improved stability, paste clarity, 
increased resistance to high temperature, high shear, low pH, 
and increases freeze-thaw stability6. Chemical modification 
of starch commonly implicates oxidation, hydrolysis or 
etherification of the available hydroxyl groups on the α-D-
glucopyranosyl units that form a starch polymer. To improve 
specific properties chemical modifications are carried out 
employing techniques such as oxidation, cross-linking, 
degrading and substitution reactions. As starch is a 
polyfunctional compound cross-linking of starch can be 
achieved. A low degree of substitution could result in key 
changes in starch functionality. In the pharmaceutical sector, 
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modified starches have found great use in the development 
of conventional and novel drug delivery systems7,8.  Acid 
treatment of starch devoid of significant changes like starch 
granules results in the formation of modified starch that 
imparts important properties that have commercial value.  
This type of starch modification mostly occurs due to the 
attack of the acid against an amorphous unit of the starch. An 
assumption made based on electron microscopic 
identification indicated that electron-thin rings of starch 
granules of the amorphous section are completely 
disintegrated by acid modification with restricted 
disintegration of electron-dense rings9. Telmisartan belongs 
to a class of drugs called angiotensin receptor blockers 
(ARBs) it is an angiotensin II receptor antagonist. It is used in 
the treatment of high blood pressure. By blocking the action 
of angiotensin, telmisartan widens blood vessels 
(vasodilator) and reduces blood pressure. It belongs to class 
II of a pharmaceutical classification system of drugs having 
low solubility and high permeability in the biological 
systems. Studies have revealed that oral administration has 
poor bioavailability of about 50% as it is highly lipophilic 
with an aqueous solubility of 0.078 mg/mL. It is a challenge 
for researchers to increase aqueous solubility and 
dissolution of telmisartan. The easy way to attain the rapid 
disintegration of tablets is to incorporate super disintegrant 
with suitable diluents10. Superdisintegrants such as 
croscarmellose sodium, crospovidone and sodium starch 
glycolate (SSG) are commonly incorporated in tablet 
formulations to increase the rate of dissolution and thus 
increase in bioavailability of the drugs. In this study, banana 
starch tartrate (BST) was synthesized by a novel method. 
The physicochemical properties as a pharmaceutical 
excipient were characterized and its potential use as a 
disintegrant in telmisartan tablets was investigated. 
2. MATERIALS AND METHODS 
2.1. Materials 
Unripe Banana starch was obtained from the local market 
and starch was isolated in the laboratory. Telmisartan drug 
(IPCA Pharma Pvt. Ltd.) and all other chemicals were of 
analytical grade which was obtained from SIGMA, Loba 
Chemie Pvt. Ltd., Mumbai, India. 
2.2. Isolation of Starch from the unripe fruit of 
Banana11,12 
Isolation of starch was carried out by an alkaline extraction 
technique using sodium hydroxide solution. The unripe 
banana was carefully washed to remove foreign materials, 
peeled, weighed and washed. The peeled banana fruits were 
cut in-to small pieces and pulverized using a homogenizer. 
The pulp of banana fruits obtained and was mixed with 
enough quantity of water and then passed through a muslin 
cloth. Different concentrations of sodium hydroxide were 
added to separate the starch. Additional sodium hydroxide 
was eliminated by washing numerous times with deionized 
water. The filtrate was collected and allowed to settle. The 
clear supernatant fluid was discarded while sedimented 
starch was separated, washing with alcohol was given and 
dried at 40°C. 
2.3. Synthesis of a novel super disintegrant banana 
starch tartrate13 
Initially 10g of tartaric acid (TA) and 2g of sodium 
hypophosphite dissolved in 25mL of distilled water. To this 
10g air-dried BS, was added to produce dispersion and this 
mixture was stirred vigorously with a glass rod. Then the pH 
of the solution was adjusted to 3.5 using 10M sodium 
hydroxide. This solution was then acclimatized for 16hrs. 
The mixture was placed in a hot air oven to dehydrate at 
60°C until it gets dried. At this point, all surface moisture was 
removed, and the starch tartrate was washed away with 
distilled water to get rid of the unreacted tartaric acid.  The 
products of reaction obtained were added to 100mL of 
distilled water and centrifuged. This product was then kept 
in the oven at 60°C until it was dried completely. The 
reaction scheme for the synthesis of BST is shown in (Figure 
1). The BST product was then grounded, the yield was 
determined by passing through sieve no. ⧣80. 
 
Fig.1:- Scheme for synthesis of Banana Starch Tartrate. 
2.4. Pharmaceutical characterization of Starch and 
Banana Starch Tartrate 
2.4.1. Identification test14,15 
1g of BS and BST tartrate was boiled with 50mL of water 
separately and subjected to identification of carbohydrates 
(Molish test), carbonyl groups (Tollen’s and Benedict’s tests) 
esters (phenolphthalein and hydroxamic acid test), and 
polysaccharide (Iodine test). 
2.4.2. Particle size determination (Light Microscopy) 16 
A small amount of BS and BST was individually mixed with 
glycerol. This mixture was mounted separately onto a 
microscope slide with a coverslip and observed under 
polarized light microscopy. The mean particle size was 
determined microscopically using a standardized eyepiece.  
2.4.3. Scanning Electron Microscopy (SEM) 17 
Grain shapes and the surface structures of the BS and BST 
were observed by the SEM technique. The sample was 
mounted on a spherical aluminum stub, coated with gold by 
using an ion sputter and was examined by SEM at an 
accelerating potential difference of 20kV.  
2.4.4. Fourier Transform Infra-Red (FTIR) 
spectroscopy18 
FTIR was recorded on samples prepared in potassium 
bromide (KBr) disks employing a BRUKER FT–IR, (Tokyo, 
Japan). KBr disks of samples were prepared at 6-8 tons 
hydrostatic press and analysed samples between scanning 
ranges 500 to 4000 cm-1. The compatibility of BST with the 
selected drug Telmisartan (T) was compared. The presence 
of additional peaks corresponding to the functional groups 
was noted. 
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2.4.5. Paste clarity19 
The clarity (transmittance % at 650nm) of BS and BST was 
measured. A 1% aqueous suspension of starch near-neutral 
pH was heated in a boiling water bath for 30 min with 
intermittent shaking. After the suspension was cooled for 
1hr. at 25°C, the light transmittance at 650nm was read 
against water blank. 
2.4.6. Moisture content20 
A total of 3g quantity each of BS and BST was placed in the 
oven at 105 ºC for 3 hrs. and weighed. Triplicate readings 
were taken and the mean was calculated. The ratio of the 
final weight to the initial weight was expressed in terms of 
percentage. 
2.4.7. Swelling capacity21 
The tapped volume occupied by 10g of each BS and BST (Vd) 
in a 100mL measuring cylinder was noted. The powder was 
then added in 85mL of deionized water and volume was 
made up to 100mL with deionized water. After 18hrs. of 
standing, the volume of the sediment, (Vw) was noted and 
the swelling capacity was determined by using the formula;  
Swelling capacity = Vw – Vd  
2.4.8. Ash Value of starch22 
A total of 2g quantity of BS and BST was weighed into a silica 
crucible and incinerated. The determination of ash value was 
done by measurement of the residue left after complete 
combustion in a muffle furnace at 550°C. 
2.4.9. Determination of pH23 
The pH of 1% w/v slurry of BS and BST in water was 
determined by digital pH meter (Lab-India Analytical 
Instruments Pvt. Ltd., Mumbai, India). 
2.4.10. Solubility24 
The solubility of 1%w/v of BS and BST were tested in water, 
aqueous buffers (pH 1.2, 6.8, 7.4 and 7.5) and organic 
solvents (methanol, chloroform, acetone, and ether) at 
30±0.2°C. 
2.4.11. Viscosity25 
The relative viscosity of 1% w/v BS and BST dispersion in 
water was measured using 10cm3 U-tube Ostwald at 
30±0.2°C. 
2.4.12. Gelling property26 
The gelling property of BS and BST was estimated by heating 
10% w/v dispersion in the water at 60, 70, 80, 90 and 100°C 
for 15min with occasional stirring.  
2.5. Flow properties of starch and starch Tartrate 
27,28,29,30 
2.5.1. Angle of repose  
It was determined by allowing BS and BST powder to flow 
through a funnel and fall freely on to a surface. Further 
addition of powder was stopped as soon as the pile has 
touched the tip of the funnel. A circle was drawn around the 
pile without any disturbance. The height and diameter of the 
resulting cone were measured. The same process was 
repeated three times and the average value was noted. The 
angle of repose was calculated by using the following 
equation: Tan θ = h/r 
Where h = height of the powder cone; r = radius of the 
powder. 
2.5.2. Bulk density 
A sufficient quantity of BS and BST was passed through a 
1.00 mm (no.18) screen to disrupt the agglomerates that 
were formed during storage. Into a dry 250mL cylinder, 
approximately 100g of the test sample (M) was introduced. 
The cylinder was carefully filled and the level of powder was 
accustomed without compressing and the unsettled apparent 
volume (Vo) was noted. Bulk density was calculated, in g/mL.  
Using the formula: Bulk density = M/Vo 
2.5.3. Tapped density 
Accurately weighed quantity of BS and BST was added into a 
measuring cylinder. Mechanically the cylinder comprising 
the sample was tapped by elevating the cylinder and 
permitting it to drop under its weight employing an 
appropriate mechanical tapped density tester at a minimal 
rate of 300 drops/min. The cylinder was tapped 500 times 
and the tapped volume (Va) was measured. The technique 
was repeated for an added 750 tapings and again the tapped 
volume was noted as (Vb). If the difference between Va and 
Vb was <2%, Vb was the final tapped volume (Vf). If the 
difference was higher, the tapings were repeated for an 
additional 1,250 times, and then the tapped density was 
calculated using the following formula:  
Tapped density = M / Vf       
Where M = weight of the sample taken; Vf = final tapped 
volume 
2.5.4. Carr’s index 
The compressibility index of BS and BST granules was 
determined using Carr’s compressibility index, as follows: 
                               (Tapped density-Bulk density) 
Carr’s index =                                                                   X 100 
                                           Tapped density  
2.5.5. Hausner’s ratio 
The Hausner’s ratio of BS and BST was determined using the 
following formula: 
                                        Tapped density  
 Hausner’s ratio =                                 
                                           Bulk density 
2.6. Formulation of tablet by direct compaction 31 
The tablets (200mg) were prepared by direct compaction 
using drug telmisartan (20mg), Microcrystalline cellulose 
(MCC) 50% w/w as a binder, mannitol (Q.S.) as a diluent, 
Sodium lauryl sulfate (SLS) 1% w/w as a wetting agent, and 
magnesium stearate (2.5% w/w) as lubricants. The 
composition of different formulation of telmisartan was 
prepared in which different super-disintegrants were 
selected with various combinations. A series of tablets were 
prepared as control (F1) employing banana starch tartrate 
BST (F2), Crospovidone (F3) and Sodium starch glycolate 
(SSG) (F4) as disintegrant at concentrations of 5 % w/w 
separately and combinations of this super-disintegrant with 
starch tartrate were compared shown in (Table 1). Each 
ingredient was weighed accurately, blended and compressed 
into tablets and subjected to evaluation. 
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Table 1: Formulation of Telmisartan tablet by direct compression 
Sr. No Ingredients F1 F2 F3 F4 F5 F6 F7 
1 Telmisartan 20mg 20mg 20mg 20mg 20mg 20mg 20mg 
2 MCC 100mg 100mg 100mg 100mg 100mg 100mg 100mg 
3 Starch Tartrate - 2mg - - - 2mg 2mg 
4 Crospovidone - - 2mg - 2mg 2mg - 
5 SSG - - - 2mg 2mg - 2mg 
6 SLS 2mg 2mg 2mg 2mg 2mg 2mg 2mg 
7 Magnesium stearate 6mg 6mg 6mg 6mg 6mg 6mg 6mg 
8 Mannitol 72mg 70mg 70mg 70mg 68mg 68mg 68mg 
TOTAL 200mg 200mg 200mg 200mg 200mg 200mg 200mg 
MCC.: Microcrystalline cellulose, SSG.: Sodium starch glycolate, SLS.: Sodium lauryl sulfate 
 
2.7. Evaluation of Tablets  
2.7.1. Weight variation32 
The weight variation test of the tablets was determined as 
per I.P. twenty tablets from each batch were randomly 
selected weighed individually and average weights were 
determined. 
2.7.2. Thickness33 
The thicknesses of the tablets were determined using a 
Vernier caliper, 20 tablets from each batch were used and 
average values were calculated. 
2.7.3. Hardness Test34 
Monsanto hardness tester was utilized to determine the 
hardness of the manufactured tablets. From each batch, five 
tablets were randomly selected and were subjected to test. 
The mean of these five tablets was given in the table.  
2.7.4. Friability35 
Friability is a measure of tablet strength, which can be 
determined by using Roche friabilator. Ten tablets were 
selected and the weight was determined. Later these tablets 
were located in the friabilator and endorsed to make 100 
revolutions at 25rpm. These tablets were then sifted, re-
weighed, and calculated for percent weight loss. 
2.7.5. Disintegration Test 36,37 
Six tablets were taken in the disintegration apparatus. A set 
of six glass tubes of about 3 inches long with the top opened 
is held against a 10-mesh screen at the foot end of the basket 
rack assembly. To test the disintegration time the individual 
tablet was added in each tube. Later basket rack was placed 
in a 1litre beaker of water at 37ºC ± 2ºC. A standard motor 
driver device was used to move the basket assembly up and 
down over a distance of 5-6 cm at a frequency of 28-32 
cycles per minute. The time taken for the individual tablet to 
break into small particles was noted. To meet the IP standard 
all particles of the tablet should pass over the 10-mesh 
screen at a specified time. From this mean disintegration, 
time was determined.  
3. RESULTS AND DISCUSSION 
Starch extracted from unripe banana fruit had a slight 
yellowish tinge hence bleaching was carried out with 
ethanol. On a dry basis, 56.3% of starch was obtained. Grains 
of isolated (BS) and (BST) were observed under the light 
microscope (Figure 2) and an SEM showed in (Figure 3) was 
the same, Presence of Starches grains with the diameter 
ranging between 25µ and 44µ. 
 
 
Fig.2:- Light microscopy of BS & BST 
Banana starch Starch Tartrate 
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Fig. 3:- Morphology of the BS & BST as determined by SEM 
 
The shape was regular with an oval appearance. The surface 
of granules appeared to be smooth and there was no 
evidence of any fissure. (BST) showed several cracks and 
fissures on its surface. The synthesized (BST) was found to 
be fine, smooth, free-flowing amorphous powder, non-
hygroscopic powder, with no characteristic odour or taste 
and with a yield of 85.4%.  An equal amount of (BS) and 
Tartaric Acid (TA) was optimum for the synthesis of banana 
starch tartrate. The (BST) did not melt during heating but 
charred at 180 ± 0.8°C.  The synthesized (BST) confirmed 
test for the presence of carbohydrates, carbonyl groups, and 
esters. (BST) was insoluble in water, organic solvents 
(methanol, chloroform, ether, and acetone), and aqueous 
buffers (pH 1.2, 6.8, 7.4 and 7.5).  No gelling was observed 
even at 80°C but converted to a clear solution having a 
swelling index of 1.88 that has shown faster disintegration 
when incorporated in telmisartan tablets formulation. Other 
properties are summarised (Table 2). 
 
Table 2:- Pharmaceutical characterization of BS and BST 
Sr. No. Characterization of Starch Banana Starch Banana Starch tartrate 
1.  State Amorphous powder Amorphous powder 
2.  Odour No odour A characteristic odour 
3.  Taste Tasteless Bitter 
4.  Colour White White 
5.  Carbohydrates (Molish’s test) + Ve + Ve 
6.  Carbonyl group (Tollen’s test) + Ve + Ve 
7.  Esters (Phenolphthalein test) + Ve + Ve 
8.  Iodine test + Ve + Ve 
9.  
Projected diameter 
 (optical microscopy) 
34.3±2.1µm 42.8±3.2µm 
10.  Average Grain size (µ) 38.04 µm 42.8 µm 
11.  Paste clarity  10.6% 12.91% 
12.  Moisture content 10.0±2.2% 18.0±1.8% 
13.  Loss on drying 12.2±3.6% 16.0±2.3% 
14.  Swelling capacity 2.17 ± 0.72 1.88± 0.36 
15.  Ash Value (% w/w) 1.2 ± 0.8 1.8 ± 0.3 
16.  Solubility 
Insoluble in aqueous and 
organic solvents 
Insoluble in aqueous and 
organic solvents 
17.  Viscosity 2.8643cps 2.1662cps 
18.  Gelling property 
Gelling at 80°C a turbid 
solution 
No gelling at 80°C a clear 
solution 
19.  Melting point 
Did not melt  
but  charred  at 160 °C 
Did not melt  
but charred at 180 °C 
20.  Angle of repose 23.21° ± 1.24 19.29° ± 0.80 
21.  Bulk density (g/cm3) 0.51 ± 0.32 0.55 
22.  Tapped density (g/cm3) 0.61 ± 0.21 0.90 
23.  Compressibility index 14.23 12.86 
24.  Carr’s index (%) 17.91 ± 1.13 38.9 
25.  Hausner’s ratio 1.21 ± 0.16 1.63 
 
 
 
BS BST 
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The Fourier-transform infrared spectroscopy (FTIR) spectrum of Banana Starch (BS) Banana Starch tartrate (BST), Telmisartan 
(T), Telmisartan and starch tartrate (TBST) is shown in Figure 4.  
 
Fig.4:- Fourier-transform infrared spectroscopy (FTIR) of BS, BST, T, and TBST 
 
The FTIR spectra of (BS) showed peaks at wave numbers 
765–930, 1159, 1425, 1646, 2130, 2931 and 3422 cm-1 
confirming the polysaccharide nature of the (BS). Spectra of 
(BS) showed three characteristics peaks between 900 cm-1 
and 1159 cm-1, indicating the occurrence of C-O stretching. A 
prominent band appeared at 930 cm-1, which showed 
sensitivity to water. The peak at 1159 cm-1 may be referred 
to as anhydrous glucose ring C-O stretch of C-O-H in starch. 
The band at 1646 cm-1 attributed to deformation vibrations 
of hydroxyl groups. The peak near 2931 cm-1 showed 
stretching vibration of -CH2. The peaks at about 3422 cm-1 
are characteristics of hydroxyl group stretching vibration. 
The spectra (BST) showed peaks absorption at 1691cm-1 
characteristic peaks of ester, so it can be concluded that 
starch tartrate was formed when starch was allowed to react 
with tartaric acid. A typical FTIR spectrum of telmisartan (T) 
exhibits at 3501 cm-1   (N-H stretch) and 1692.58 cm-1  
Carboxylic acids (COOH) was observed for the C=O 
stretching band 2955 cm-1  (aliphatic C-H stretch), and a 
weaker C-O stretch around 1263 cm-1, whereas the 
carboxylate group (COO−) exhibits two characteristics 
coupled carbonyl absorption band at 1605 cm-1 
(asymmetric) and around 1450 cm-1  (symmetric) presence 
of C=C aromatic group. The carbonyl stretches of the 
carboxylic acid of telmisartan were observed at 1692 cm-1, 
3546 cm-1  (N-H stretch), which is not affected and appeared 
at the same in (TBST). The presence of all these peaks and 
the non-appearance of other new peaks in the complex of 
(TBST) indicate there is surely no chemical interaction 
amongst banana starch tartrate and telmisartan.  
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Table 3: Evaluation of Telmisartan Tablets 
Sr. 
No 
Batch 
Weight                     
variation 
(n =20) 
Thickness 
(mm)  
(n =10) 
Hardness  
(kg / cm2)     
(n =6) 
Friability (%) 
(n =20) 
Disintegration 
Time (Sec) 
 (n =6) 
1.  F1 4.0 ±0.8 3.02 ±0.05 4.8±0.04 0.95±0.04 512±37 
2.  F2 3.5 ±0.4 3.01 ±0.01 3.2±0.07 0.76±0.02 58±43 
3.  F3 3.8 ±0.2 3.03 ±0.04 2.5±0.09 0.68±0.01 42 ±09 
4.  F4 2.5 ±0.1 3.05 ±0.02 2.4±0.07 0.83±0.04 38±08 
5.  F5 3.5 ±0.3 3.04 ±0.02 3.6±0.03 0.73±0.03 42 ±11 
6.  F6 3.0±0.2 3.01 ±0.01 2.5±0.05 0.86±0.01 37 ±21 
7.  F7 2.2 ±0.5 3.02 ±0.04 2.5±0.08 0.66±0.02 36 ±06 
All values are mean ±SD.  
 
The bulk density, angle of repose and compressibility index 
of both (BS) and (BST) were comparable. In all the cases the 
values of angle of response were ≤30°, which indicates that 
all the (BS) and (BST) was free-flowing (Table 2).  Evaluation 
of (BST) showed a significant increase in bulk and tapped 
density with an increase in the concentration of (BST) and 
the good correlation was observed between concentrations 
of super disintegrants. As the mixture was free flowing, all 
the tablets that were obtained were of uniform weight due to 
homogeneous die fill. The unintended degree of the strength 
of a tablet is its tensile strength. Greater tensile strength and 
lower friability were observed in this study which implies a 
good strength to tablets that were prepared using (BST). 
Telmisartan tablets formulated by using banana starch, 
banana starch tartrate, crospovidone, sodium starch 
glycolate, and its combination passed the friability test and 
was found to be well within acceptable limits for all the 
tablet formulation. The friability test showed that the banana 
starch tartrate tablets had similar binding strength 
compared to super disintegrant containing tablets (Table 3). 
Weight variation test exhibited no tablet deviating from 
average weight by 4.2%. Thus all tablets have passed the 
weight variation test as per the official limit. The 
disintegration time of banana starch tartrate tablets was 
almost similar at all the concentrations employed compared 
to those of super-disintegrants which may be due to higher 
swelling capacity (Table 2). Swelling capacity alone or their 
combination is the basic properties of disintegration. Though 
gelling of superficial particles delays further penetration of 
dissolution medium into the tablet and avoids disintegration. 
The rapid disintegration of telmisartan tablets formulated 
using (BST) may perhaps be owing to its hydrophilic nature 
that rendered by the presence of a free COOH group of (TA). 
This perhaps facilitated the diffusion of water into the tablets 
by capillary action, therefore, creating pores that lead to 
quick disintegration. 
4. CONCLUSION 
The work provides a detailed report of some insights into the 
relative effectiveness of (BST) as a disintegrating agent in 
comparison to super disintegrants. The results indicated that 
BS presented a difference in physic-chemical properties that 
can be caused by starch granule size and morphology.  The 
disappearance of pink colour in the ester test confirmed the 
presence of ester, i.e., (BST). As the (BST) was amorphous, 
smooth, free-flowing powder and it had got all the 
characteristics of super disintegrants it was concluded that 
the (BST) can be used as a novel super disintegrant in the 
tablets formulation. It can be concluded that in this study 
(BST) was synthesized by treating (BS) with tartaric acid 
(TA) at elevated temperatures in semi-dry condition. The 
prepared (BST) showed promising physicochemical 
properties suggesting suitability as a disintegrant in tablet 
formulations of poorly soluble drug telmisartan. Preserving 
its low swelling capacity, (BST) has presented much superior 
tablet disintegrating properties when compared with sodium 
starch glycolate and crospovidone. Thus it can be concluded 
that banana starch tartrate could be employed as a 
promising semi-synthetic disintegrant in tablets formulation.  
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